10x Genomics, Inc. — Director's Dealing 2019

Sep 12, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2019-09-11

Reporting Person: SULIMAN SHEHNAAZ (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$30.00	2029-08-07	Class B Common Stock (100000)		Direct

Footnotes

F1: One forty-eighth of the shares subject to the option vested on September 7, 2019 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares.

F2: Each share of Class B Common Stock shall be reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock.